Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

PRP shows promise for improving facial wrinkles, skin elasticity, and hair growth, but more research is needed to standardize its use and understand its effects.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Lasers, microneedling, and PRP improve skin rejuvenation and repair, with PRP enhancing the effects when combined with other treatments.

Obesity is linked to various skin disorders, which can help with early diagnosis and prevention of long-term health issues.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

The document concludes that careful surgical methods and choosing the right materials are key for successful scalp, skull, and frontal sinus reconstruction.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Dermatologists play a key role in identifying and documenting signs of abuse and injury for forensic investigations.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

New treatments for male hair loss show promise but need more research for safety and effectiveness.

Finasteride effectively treats central serous chorioretinopathy.

Platelet-rich treatments can help improve wound healing and tissue repair.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.